×
Top Dividend Stocks to Buy before the prices go up!
Download Your Free Stock Report!
Our expert team of analysts helps you with Buy, Hold & Sell recommendations!
Our goal is to provide you with best stock market recommendations At the Right Price - At the Right Time
To Get Free Reports Register Now
Register Now
By clicking this button, you agree to our
Terms of Service
and
Privacy Policy
& our Financial Services Guide
(FSG)
×
7 Days Free Trial
Submit
info@aceinvestors.com.au
(02) 9199 9639
Members Login
Contact Us
Home
Research Reports
Daily Recommendations
Dividend Income Report
Growth Stock Report
Speculative Stock Report
US Stock Report
Under 50 cents Special
US Market Report
Segment Specific
Blue Chip
Mid Cap
Small Cap
IPO
Sector Coverage
Banking
Entertainment
Financials
Telecom
Healthcare
Food, Beverage & Tobacco
Insurance
Services and Materials
Technology & IT
IPO
Mining
Energy
Media
Industrial
Utility
Retail
Real Estate
Airlines & Transportation
Consumer Discretionary
Editorial
Sample Report
Subscribe
Privacy Policy
Home
Privacy Policy
Imricor Medical Systems Inc (ASX: IMR) – Ma...
By ACE Investors / 06 Mar 2024
Read More
Monash IVF Group Limited (ASX: MVF): Monash I...
By ACE Investors / 05 Mar 2024
Read More
Audeara Limited (ASX: AUA): Focused on improv...
By ACE Investors / 05 Mar 2024
Read More
Mayne Pharma Group Limited (ASX: MYX) Deliver...
By ACE Investors / 29 Feb 2024
Read More
Eli Lilly and Company (NYSE: LLY) – Acceler...
By ACE Investors / 22 Feb 2024
Read More
Imagion Biosystems (ASX: IBX): Announced posi...
By ACE Investors / 21 Feb 2024
Read More
Healthco Healthcare and Wellness REIT (ASX: H...
By ACE Investors / 16 Feb 2024
Read More
Coherus Biosciences Inc (NASDAQ: CHRS) – A ...
By ACE Investors / 15 Feb 2024
Read More
Next Science Limited (ASX: NXS): Signed a Con...
By ACE Investors / 13 Feb 2024
Read More
Resmed Inc (ASX: RMD): Track Record of Strong...
By ACE Investors / 09 Feb 2024
Read More
MGC Pharmaceuticals Limited (ASX: MXC): Devel...
By ACE Investors / 07 Feb 2024
Read More
Microba Life Sciences Limited (ASX: MAP): Exp...
By ACE Investors / 06 Feb 2024
Read More
‹ First
<Previous
8
9
10
11
12
Next >
Last ›
ABN No: 70 637 702 188 | ACN NO: 637 702 188
Copyright © 2024 ACE Investors. All Right Reserved. Design by
Ace Investors